Advances in the pharmacological management of systemic lupus erythematosus

A Tsoi, D Nikolopoulos, I Parodis - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Despite setbacks in clinical trials for systemic lupus erythematosus (SLE), three
drugs have been approved for SLE and lupus nephritis (LN) treatment in the past decade …

[引用][C] Advances in the pharmacological management of systemic lupus erythematosus.

A Tsoi, D Nikolopoulos, I Parodis - Expert Opinion on …, 2024 - europepmc.org
Despite setbacks in clinical trials for systemic lupus erythematosus (SLE), three drugs have
been approved for SLE and lupus nephritis (LN) treatment in the past decade. Several …

Advances in the pharmacological management of systemic lupus erythematosus

A Tsoi, D Nikolopoulos, I Parodis - Expert Opinion on …, 2024 - diva-portal.org
INTRODUCTION: Despite setbacks in clinical trials for systemic lupus erythematosus (SLE),
three drugs have been approved for SLE and lupus nephritis (LN) treatment in the past …

[PDF][PDF] Advances in the pharmacological management of systemic lupus erythematosus

A Tsoi, D Nikolopoulos, I Parodis - 2024 - researchgate.net
Introduction: Despite setbacks in clinical trials for systemic lupus erythematosus (SLE), three
drugs have been approved for SLE and lupus nephritis (LN) treatment in the past decade …

Advances in the pharmacological management of systemic lupus erythematosus

A Tsoi, D Nikolopoulos, I Parodis - Expert opinion on … - pubmed.ncbi.nlm.nih.gov
Introduction Despite setbacks in clinical trials for systemic lupus erythematosus (SLE), three
drugs have been approved for SLE and lupus nephritis (LN) treatment in the past decade …